DOW vs NERV · P/E 74, rev $39.97B vs P/E 2.2, $12.4M cap
Dow Inc (DOW) versus Minerva Neurosciences Inc (NERV) — a side-by-side from cached financials, not a winner call.
Dow Inc (DOW) is a chemicals company listed on US.
Minerva Neurosciences Inc (NERV) is a biotechnology company listed on US.
Latest reported DOW revenue for 2025-12-31 was $39.97B. Net income was -$2.44B. Revenue was down 7.0% from 2024-12-31 to 2025-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
NERV does not have a complete income-statement cache yet.
DOW currently screens at market cap $20.89B and trailing P/E 73.9. NERV currently screens at market cap $12.4M and trailing P/E 2.2.
Not investment advice. Open the DOW and NERV stock pages for the full models.
Not investment advice.